AGC Wakasa Chemicals, part of Japanese group AGC, has completed a new large-scale production line at its Kaminaka Plant in Fukui prefecture, Japan, as it expects demand...

AGC Biologics, a biopharma CDMO, has completed the expansion of its manufacturing capacity at the company’s Cell & Gene Center of Excellence in Milan, Italy.

AGC Pharma Chemicals Europe, part of Japanese conglomerate AGC, is expanding capacity for synthetic pharmaceuticals at its site in Malgrat de Mar, Spain. The CDMO will...

AGC Biologics is expanding capacities for plasmid DNA (pDNA) and messenger RNA (mRNA) at its site in Heidelberg, Germany. The company said in June that it had agreed to...

AGC Biologics, US biopharma CDMO, has signed an agreement to buy a cell and gene therapy manufacturing facility in Longmont, Colorado, from Novartis Gene Therapies...

AGC Biologics has agreed to supply plasmid DNA (pDNA) to Pfizer/BioNTech for their RNA-based Covid-19 vaccine. The biopharma CDMO based in Heidelberg, Germany, will...

AGC Biologics, a biopharma CDMO, is planning to expand its cell and gene therapy center of excellence in Milan, Italy, to increase capacities and implement viral vector...